Market Research Logo

Asahi Kasei Pharma Corp - Strategic SWOT Analysis Review

Asahi Kasei Pharma Corp - Strategic SWOT Analysis Review

- provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
Highlights

Asahi Kasei Pharma Corp (Asahi Kasei Pharma), a subsidiary of Asahi Kasei Corp, discovers, develops, manufactures, and markets pharmaceuticals and diagnostic products. The company's portfolio encompasses prescription drugs, diagnostic reagents, and enzymes for diagnostic reagents. Its prescription drugs are used for the treatment of osteoporosis pain, disseminated intravascular coagulation, bone loss, dysuria accompanying benign prostatic hyperplasia, nocturia, proteinuria in nephrotic syndrome and lupus nephritis, and difficulty in urination. Asahi Kasei Pharma offers assay kits that determine glycemic control and detect prediabetes. The company’s pipeline includes candidates for acute exacerbation of idiopathic pulmonary fibrosis; chemotherapy-induced peripheral neuropathy; osteoporosis with high risk of fracture; Lupus nephritis and nephrotic syndrome; and for severe sepsis with coagulopathy. It manufactures pharmaceuticals and diagnostic kits at its manufacturing plants in Shizuoka, and Nagoya in Japan. Asahi Kasei Pharma is headquartered in Tokyo, Japan.

Asahi Kasei Pharma Corp Key Recent Developments

May 18,2017: Zoll Technologies for Improving CPR Quality to be Showcased at NTI 2017
Feb 17,2017: ZOLL Expands the Rescuer Experience at EMS

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.


Section 1 - About the Company
Asahi Kasei Pharma Corp - Key Facts
Asahi Kasei Pharma Corp - Key Employees
Asahi Kasei Pharma Corp - Major Products and Services
Asahi Kasei Pharma Corp - History
Asahi Kasei Pharma Corp - Company Statement
Asahi Kasei Pharma Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Asahi Kasei Pharma Corp - Business Description
R&D Overview
Asahi Kasei Pharma Corp - SWOT Analysis
SWOT Analysis - Overview
Asahi Kasei Pharma Corp - Strengths
Asahi Kasei Pharma Corp - Weaknesses
Asahi Kasei Pharma Corp - Opportunities
Asahi Kasei Pharma Corp - Threats
Asahi Kasei Pharma Corp - Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Asahi Kasei Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Asahi Kasei Pharma Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Asahi Kasei Pharma Corp, Recent Deals Summary
Section 4 – Company’s Recent Developments
May 18, 2017: Zoll Technologies for Improving CPR Quality to be Showcased at NTI 2017
Feb 17, 2017: ZOLL Expands the Rescuer Experience at EMS
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Asahi Kasei Pharma Corp, Key Facts
Asahi Kasei Pharma Corp, Key Employees
Asahi Kasei Pharma Corp, Major Products and Services
Asahi Kasei Pharma Corp, History
Asahi Kasei Pharma Corp, Other Locations
Asahi Kasei Pharma Corp, Subsidiaries
Asahi Kasei Pharma Corp, Key Competitors
Asahi Kasei Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Asahi Kasei Pharma Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Asahi Kasei Pharma Corp, Recent Deals Summary
List of Figures
Asahi Kasei Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Asahi Kasei Pharma Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report